Cardio-Metabolic

Cardio-Metabolic includes companies targeting cardiovascular disease, obesity, diabetes, lipid disorders, and related metabolic conditions. This page highlights businesses exposed to some of the largest and most competitive treatment categories in biotech and pharma.

Why watch Cardio-Metabolic

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Cardio-Metabolic news

The latest feed items from companies currently grouped under Cardio-Metabolic.

1. 01
   2026-07-14 11:00 EST

   BEATHeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device

   Source: HeartBeam

2. 02
   2026-07-13 10:59 EST

   BMYU.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

   Source: BMYBristol-Myers Squibb Company

3. 03
   2026-07-10 19:01 EST

   MRKFDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC)

   Source: Merck

4. 04
   2026-07-10 10:06 EST

   MRKFDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC) - Merck.com

   Source: Merck

5. 05
   2026-07-10 10:06 EST

   MRKMerck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV - Merck.com

   Source: Merck

6. 06
   2026-07-10 10:06 EST

   MRKMerck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4 - Merck.com

   Source: Merck

7. 07
   2026-07-09 19:07 EST

   MRKGilead and Merck Announce Positive Topline Results from two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment - Merck.com

   Source: Merck

8. 08
   2026-07-09 11:56 EST

   MRKFDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma (ccRCC) - Merck.com

   Source: Merck

9. 09
   2026-07-09 11:56 EST

   MRKU.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease - Merck.com

   Source: Merck

10. 10
    2026-07-09 11:56 EST

    MRKMerck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC) - Merck.com

    Source: Merck

11. 11
    2026-07-09 11:56 EST

    MRKEuropean Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer - Merck.com

    Source: Merck

12. 12
    2026-07-08 15:00 EST

    AGIOQuality Beyond Compliance: Malik Khan, Hologic VP of Quality

    Source: Agios Pharmaceuticals, Inc.

13. 13
    2026-07-08 15:00 EST

    AGIOMireille Akilian on Women’s Health & GYN Surgical Innovation | Hologic

    Source: Agios Pharmaceuticals, Inc.

14. 14
    2026-07-08 15:00 EST

    AGIOFibroid Care Innovation: Listening, Learning, Engineering | Hologic

    Source: Agios Pharmaceuticals, Inc.

15. 15
    2026-07-08 15:00 EST

    AGIOTom Kelly, Co-Inventor of the T-Score, on the Science of DXA and Its Role in Protecting Women’s Bone Health Across Life Stages

    Source: Agios Pharmaceuticals, Inc.

16. 16
    2026-07-03 01:30 EST

    MISTMilestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Source: Milestone Pharmaceuticals Inc.

17. 17
    2026-07-02 20:01 EST

    NAMSNewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Source: NewAmsterdam Pharma

18. 18
    2026-07-01 12:00 EST

    NAMSNewAmsterdam Pharma Announces Upcoming Presentations at the Alzheimer's Association International Conference (AAIC) 2026

    Source: NewAmsterdam Pharma

19. 19
    2026-06-30 11:00 EST

    BEATHeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule

    Source: HeartBeam

20. 20
    2026-06-25 13:46 EST

    BEATHeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition

    Source: HeartBeam

Companies in Cardio-Metabolic

27 companies tagged with Cardio-Metabolic.

Frequently Asked Questions